NBTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nanobiotix SA (NBTX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong analyst support with consistent price target upgrades, positive sentiment from recent preclinical data, and bullish technical indicators. Despite hedge fund selling, the company's innovative technology and pipeline advancements make it a compelling long-term opportunity.
The technical indicators are bullish. The MACD histogram is positive and expanding, the RSI is neutral at 61.504, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level of 32.119, with resistance levels at 33.966 and 35.108, and support levels at 30.273 and 29.131.
Positive preclinical data presented at the AACR annual meeting, showcasing the potential of the Nanoprimer platform in cancer treatment.
Strong analyst support with multiple price target upgrades and buy ratings.
Bullish technical indicators suggest upward momentum.
Hedge funds are selling, with a significant increase in selling activity (1048.78%) over the last quarter.
Pre-market price is down by 3.09%, indicating short-term bearish sentiment.
No financial data available for analysis.
Analysts are highly positive on the stock, with multiple buy ratings and price target upgrades. H.C. Wainwright raised its target to EUR 34, Guggenheim to $36, and Leerink to $37, reflecting increased confidence in the company's pipeline and technology advancements.
